Omnicell (OMCL) Tops Q4 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Omnicell (OMCL) Tops Q4 EPS by 11c

Omnicell Reports Fiscal Year and Fourth Quarter 2020 Results

February 1, 2021 4:01 PM EST

Record 2020 Total Product Bookings of $1+ billion

Full Year 2020 Revenues of $892.2 million

Ended Year with 145 Long-Term, Sole-Source Agreements with the Top 300 U.S. Health Systems

Entered 2021 with Record Product Backlog of $924 million

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its fiscal year and fourth quarter ended December 31, 2020.

This press release features... More